Literature DB >> 25705982

Transitioning to routine breast cancer risk assessment and management in primary care: what can we learn from cardiovascular disease?

Kelly-Anne Phillips1, Emma J Steel1, Ian Collins1, Jon Emery2, Marie Pirotta2, G Bruce Mann3, Phyllis Butow4, John L Hopper5, Alison Trainer1, Jane Moreton1, Antonis C Antoniou6, Jack Cuzick7, Louise Keogh8.   

Abstract

To capitalise on advances in breast cancer prevention, all women would need to have their breast cancer risk formally assessed. With ~85% of Australians attending primary care clinics at least once a year, primary care is an opportune location for formal breast cancer risk assessment and management. This study assessed the current practice and needs of primary care clinicians regarding assessment and management of breast cancer risk. Two facilitated focus group discussions were held with 17 primary care clinicians (12 GPs and 5 practice nurses (PNs)) as part of a larger needs assessment. Primary care clinicians viewed assessment and management of cardiovascular risk as an intrinsic, expected part of their role, often triggered by practice software prompts and facilitated by use of an online tool. Conversely, assessment of breast cancer risk was not routine and was generally patient- (not clinician-) initiated, and risk management (apart from routine screening) was considered outside the primary care domain. Clinicians suggested that routine assessment and management of breast cancer risk might be achieved if it were widely endorsed as within the remit of primary care and supported by an online risk-assessment and decision aid tool that was integrated into primary care software. This study identified several key issues that would need to be addressed to facilitate the transition to routine assessment and management of breast cancer risk in primary care, based largely on the model used for cardiovascular disease.

Entities:  

Mesh:

Year:  2016        PMID: 25705982     DOI: 10.1071/PY14156

Source DB:  PubMed          Journal:  Aust J Prim Health        ISSN: 1448-7527            Impact factor:   1.307


  7 in total

Review 1.  Key steps for effective breast cancer prevention.

Authors:  Kara L Britt; Jack Cuzick; Kelly-Anne Phillips
Journal:  Nat Rev Cancer       Date:  2020-06-11       Impact factor: 60.716

2.  iPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and management.

Authors:  Ian M Collins; Adrian Bickerstaffe; Thilina Ranaweera; Sanjaya Maddumarachchi; Louise Keogh; Jon Emery; G Bruce Mann; Phyllis Butow; Prue Weideman; Emma Steel; Alison Trainer; Mathias Bressel; John L Hopper; Jack Cuzick; Antonis C Antoniou; Kelly-Anne Phillips
Journal:  Breast Cancer Res Treat       Date:  2016-02-24       Impact factor: 4.872

3.  Risk Factors for Breast Cancer in Gaza Strip, Palestine: a Case-Control Study.

Authors:  Mueen Kariri; Marwan O Jalambo; Basil Kanou; Saleh Deqes; Samaher Younis; Baker Zabut; Usama Balawi
Journal:  Clin Nutr Res       Date:  2017-07-28

4.  Women's decision-making regarding risk-stratified breast cancer screening and prevention from the perspective of international healthcare professionals.

Authors:  Linda Rainey; Daniëlle van der Waal; Louise S Donnelly; D Gareth Evans; Yvonne Wengström; Mireille Broeders
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

5.  Envisioning Implementation of a Personalized Approach in Breast Cancer Screening Programs: Stakeholder Perspectives.

Authors:  Daphne Esquivel-Sada; Emmanuelle Lévesque; Julie Hagan; Bartha Maria Knoppers; Jacques Simard
Journal:  Healthc Policy       Date:  2019-11

6.  Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management Tool.

Authors:  Kelly-Anne Phillips; Yuyan Liao; Roger L Milne; Robert J MacInnis; Ian M Collins; Richard Buchsbaum; Prue C Weideman; Adrian Bickerstaffe; Stephanie Nesci; Wendy K Chung; Melissa C Southey; Julia A Knight; Alice S Whittemore; Gillian S Dite; David Goldgar; Graham G Giles; Gord Glendon; Jack Cuzick; Antonis C Antoniou; Irene L Andrulis; Esther M John; Mary B Daly; Saundra S Buys; John L Hopper; Mary Beth Terry
Journal:  JNCI Cancer Spectr       Date:  2019-09-19

7.  The iPrevent Online Breast Cancer Risk Assessment and Risk Management Tool: Usability and Acceptability Testing.

Authors:  Louisa L Lo; Ian M Collins; Mathias Bressel; Phyllis Butow; Jon Emery; Louise Keogh; Prue Weideman; Emma Steel; John L Hopper; Alison H Trainer; Gregory B Mann; Adrian Bickerstaffe; Antonis C Antoniou; Jack Cuzick; Kelly-Anne Phillips
Journal:  JMIR Form Res       Date:  2018-11-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.